Revised DH contract will benefit researchers and patients
Tuesday, 27 September 2016 10:18
The Department of Health (DH) and the Health Research Authority (HRA) have been working together to review the standard DH contract for NIHR funded research. From 4th August 2016 research funded by an NIHR research programme has been able to receive payments for start-up in advance of ethical approval. This enables more rapid, efficient and streamlined set-up of research and quicker translation of research into patient benefit.
This change will enable the appointment of skilled research staff earlier in the project leading to better quality applications for HRA Approval, fewer protocol amendment applications early on in the project, and a quicker and more efficient start up process.
'Library' of nearly 50 de-prioritised pharma compounds opens to researchers
Tuesday, 27 September 2016 10:05
A collection of 47 deprioritised pharmaceutical compounds and up to £5million is being made available to academic researchers through the latest round of the MRC-Industry Asset Sharing Initiative. The collaboration, between the MRC and six global drug companies, is the largest of its kind in the world.
UK scientists can apply for MRC funding to use any of the compounds in medical research studies to investigate the underlying mechanics of disease, which may lead to the development of more effective treatments for a range of conditions.
Both clinical (those already tested in humans) and preclinical compounds feature in the extensive collection, which includes molecules developed initially for a wide range of diseases including for cancer, ADHD, narcolepsy and diabetes.
AstraZeneca, GSK, Janssen, Pfizer, Takeda and UCB have each offered up a number of their deprioritised molecules as part of the partnership, which was initially launched in 2014.
Prizes for collaborative regenerative medicine researchers
Tuesday, 27 September 2016 10:00
The UK Regenerative Medicine Platform (UKRMP) has awarded special merit prizes to two postdoctoral researchers who have demonstrated outstanding work on leading creative new approaches to help members of the Platform work together effectively and accelerate discovery.
The UKRMP aims to address the key translational challenges of regenerative medicine – a branch of science that aims to repair or replace damaged and diseased human cells and tissues. It brings together academic expertise, innovation and knowledge with commercial and clinical end-users.
Central to the Platform are five interdisciplinary and complementary research Hubs that collectively provide a national resource to researchers by generating new tools, protocols and resources that can be utilised by other UK research groups in both academia and industry.
Symposium Takes the Pulse of IBD Research
Tuesday, 27 September 2016 09:52
The Kenneth Rainin Foundation hosted their fifth annual Innovations Symposium, “Emerging IBD Strategies,” in San Francisco in late July. Scientific leaders, trainees, researchers and clinicians from around the world attended the conference, which provides a platform to collaborate and draw inspiration from colleagues to move Inflammatory Bowel Disease (IBD) research forward. It also allows the Foundation to take the pulse of the state of the field and explore additional ways we can support and accelerate IBD research.
Page 10 of 31